SUMO-1 (6-21) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-SUMO-1 (6-21) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificitySUMO-1 (6-21)
Clonepolyclonal
Host SpeciesSheep
Reactive Specieshuman, rat
Isotypen/a
Formatunconjugated
Size0.1 mL
Concentration1ug/ul
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis antiserum recognises human SUMO-1 and not ubiquitin. SUMO-1 binds to a wide range of target proteins as part of a post-translational modification system. Unlike ubiquitin, it does not seem to target protein for degradation, but is involved in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis, apoptosis, protein stability and signal transduction. SUBUNIT: Covalently attached to a number of proteins such as PML, RANGAP1, HIPK2, SP100, p53, p73alpha, MDM2, JUN and DNMT3B. Also interacts with HIF1A, HIPK2, HIPK3, CHD3, PIAS1, EXOSC9, TDG, RAD51 and RAD52. SUBCELLULAR LOCATION: Nucleus; nuclear membrane. Nucleus; nucleoplasm; nuclear speckle. Cytoplasm. SIMILARITY: Belongs to the ubiquitin family.
ImmunogenImmunogen: A synthetic peptide (AKPSTEDLGDKKEGEY) as part of human SUMO-1 peptide (aa: 6-21) conjugated to diphtheria toxoid has been used as the immunogen. This antigen is homologous with SUMO-1 of rat. Storage Buffer: PBS, pH 7.4 with 0.02% sodium azide.
Other Names[SUMO-1, partial; SUMO-1; SUMO-1]
Gene, Accession #[SUMO-1], NCBI: JAR73250.1
Catalog #MBS4152766
Price$515
Order / More InfoSUMO-1 (6-21) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.